Growth failure and bone lesions due to desferrioxamine in thalassaemic patients.
Caruso-Nicoletti
M
M
Department of Pediatrics, University of Catania, Italy.
Di Bella
D
D
Pizzarelli
G
G
Leonardi
C
C
Sciuto
C
C
Coco
M
M
Di Gregorio
F
F
D001803:Blood Transfusion; D001847:Bone Diseases / Q000139:chemically induced*; D002614:Chelating Agents / Q000009:adverse effects*; D002648:Child; D003676:Deferoxamine / Q000009:adverse effects*; D005260:Female; D006130:Growth Disorders / Q000139:chemically induced*; D006801:Humans; D008297:Male; D017086:beta-Thalassemia / Q000628:therapy*
D002614:Chelating Agents; D003676:Deferoxamine